Ropes & Gray advised Moffitt Cancer Center and OncoBay Clinical, one of its for-profit subsidiaries, in an investment in OncoBay by Clinscience, a global clinical research organization based in Warsaw, Poland. The investment will give Clinscience’s parent company NEUCA Group a majority equity stake in OncoBay.
OncoBay is a boutique clinical research organization specializing in immuno-oncology and cell therapy, offering full-service custom curated CRO solutions for global pharmaceutical and biotech companies. The companies will work together to advance immune-oncology research for a global portfolio of clients. The transaction was announced on January 9. Financial terms were not disclosed.
The Ropes & Gray team was led by venture capital & emerging companies partner Brad Flint and tax partner Scott Pinarchick and included IP transactions partner David McIntosh, employment & benefits partners Renata Ferrari and Jenny Rikoski, tax partner Kendi Ozmon, tax counsel Gil Ghatan and employment & benefits principal Bruce Gaffney.
Stay Up To Date with Ropes & Gray
Ropes & Gray attorneys provide timely analysis on legal developments, court decisions and changes in legislation and regulations.
Stay in the loop with all things Ropes & Gray, and find out more about our people, culture, initiatives and everything that’s happening.
We regularly notify our clients and contacts of significant legal developments, news, webinars and teleconferences that affect their industries.